Analyst Price Targets — NAUT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 28, 2025 1:10 pm | — | Guggenheim | $2.50 | $1.30 | TheFly | Nautilus Biotechnology price target lowered to $2.50 from $4 at Guggenheim |
| June 27, 2024 6:11 am | Subbu Nambi | Guggenheim | $6.00 | $2.29 | StreetInsider | Guggenheim Starts Nautilus Biotechnology (NAUT) at Buy |
Latest News for NAUT
• Baylor selects the Nautilus Voyager™ Platform, now available through Early Access Program, for development of a first-in-class computational multi-omics toolkit • NIH-funded project leverages collaborators' expertise in single-molecule proteomics and protein isoform quantification to advance high-resolution cancer isoform analysis
Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call Transcript
SEATTLE, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the TD Cowen 46th Annual Health Care Conference.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NAUT.
U.S. House Trading
No House trades found for NAUT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.